Improvements were significantly greater with BDP nasal aerosol than with placebo during the first 6 weeks of treatment in children 6 to 11 years old in average morning and evening rTNSS and iTNSS ( mean treatment difference-0 .66 [ P = .002 ] and-0 .58 [ P = .004 ] , respectively ) .